References
- Vartivarian SE, Anaissie EJ, Bodey GP. Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management. Clin Infect Dis 1993; 17 (suppl 2): S481-7.
- Puccetti P, Romani L, Bistoni F. A Thl-Th2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol 1995; 3: 237–40.
- Romani L, Mencacci A, Tonnetti L et al. Interleukin-12 is both required and prognostic in vivo for T helper type 1 dif-ferentiation in murine candidiasis. J Immunol 1994; 153: 5167–75.
- Tonnetti L, Spaccapelo R, Cenci E et al. Interleukin-4 and 10 exacerbate candidiasis in mice. Eur J Immunol 1995; 25: 1559–65.
- Romani L, Mencacci A, Grohmann U et al. Neutralizing antibody to interleukin-4 induces systemic protection and T-helper type 1-associated immunity in murine candidiasis. J Exp Med 1992; 176: 19–25.
- Cenci E, Mencacci A, Del Sero G, Bistoni F, Romani L. Induction of protective Thl responses to C. albicans by anti-fungal therapy alone or in combination with an Interleukin-4 antagonist. J Infect Dis 1997; 176; 217–26.